FDA Panel Says LINX Implantable Device to Treat GERD is Safe, Effective

The FDA’s Gastroenterology-Urology Devices Panel voted unanimously that LINX’s Reflux Management System, a laparoscopically implanted device designed to treat gastroesophageal reflux disease, has a favorable risk-benefit profile and was safe and effective, according to an FDA report.

Advertisement

The system is a sterile, single-use device designed to support a weak lower esophageal sphincter and prevent reflux. Consisting of titanium beads with a magnetic core strung together on a titanium wire, the device is placed around the gastroesophageal junction at the LES. The magnetic beads rest against each other to prevent the LES from opening. The magnetic attraction is disrupted when the patient swallows to allow food to pass through. The panel did not vote specifically on whether to recommend approval.

Related Articles on Gastroenterology:
Fecal Immunochemical Test Now Available to Patients at Home
Global Gastrointestinal Device Market to Reach $14.6B
Gastrointestinal Endoscopic Device Market Expected to Hit $2.7B by 2018

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.